(Q44018855)

29 November 2017

title

Interleukin-2 is one of the targets of 1,25-dihydroxyvitamin D3 in the immune system (English)

1 reference

29 November 2017

Candace J Bemiss

1

1 reference

29 November 2017

Brett D Mahon

2

1 reference

29 November 2017

Adam Henry

3

1 reference

29 November 2017

Veronika Weaver

4

1 reference

29 November 2017

Margherita T Cantorna

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Archives of Biochemistry and Biophysics

29 November 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 November 2017

volume

402

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

249-254

1 reference

1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900082-6

1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900082-6

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900082-6

1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900082-6

Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900082-6

Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900082-6

In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900082-6

1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900082-6

Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900082-6

Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900082-6

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900082-6

Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900082-6

Characterization of the mucosal cell-mediated immune response in IL-2 knockout mice before and after the onset of colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900082-6

Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900082-6

10.1016/S0003-9861(02)00082-6

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference